← DeepTechTracker
FluoRok team group photograph, without individual name identification

FluoRok announces $30 million to make fluorochemicals without hydrogen fluoride

FluoRok team. Image: FluoRok. Individuals are not identified in this photograph.

FluoRok announced an oversubscribed $30 million (£22.8 million) Series A financing on November 5. Orano Venture Fund / Supernova Invest led the round, with Bidra Innovation Ventures and returning investors Oxford Science Enterprises, BGF, GGF, Volta Energy Technologies and the University of Oxford. The announcement also names EverQuest Capital Partners, CPI Enterprises, WS Investment and angel investors.

The company describes the round as equity financing but also says it included approximately $1.3 million (£1 million) of Innovate UK Investor Partnerships grant funding. It does not provide a clean equity-versus-grant reconciliation. The $30 million is therefore presented here as the announced Series A financing figure, not as independently confirmed equity-only proceeds. Earlier rounds of about $14 million and more than $13 million of earlier public funding are separate historical figures.

FluoRok is an Oxford spinout developing a way to make fluorochemicals without using hydrogen fluoride, or HF, a highly toxic and corrosive chemical used in the conventional process. Fluorochemicals contain fluorine and are important in medicines, crop-protection products and battery materials. Its process uses mechanical activation and base chemistry instead of the traditional acid-and-high-temperature route. Mechanical activation means using physical force to help drive a chemical reaction.

The company says the process can use lower-grade mined fluoride and fluoride recovered from industrial waste, with off-the-shelf industrial equipment. Its first markets include inorganic fluorides for pharmaceutical and agrochemical uses, and lithium hexafluorophosphate, or LiPF6, a salt used in lithium-ion battery electrolytes. Electrolyte is the material through which charged particles move inside a battery. Removing HF from the manufacturing route does not mean every fluorinated product is harmless or that all environmental questions disappear.

FluoRok reports completed pilot qualifications. The new financing will support demonstrator facilities for its reagents and battery electrolyte salts, repeatable production, larger-scale customer validation, hiring and commercial partnerships. These are steps toward industrial manufacturing, not evidence that full industrial capacity is already in operation. Its claims of lower cost and simpler infrastructure remain scale-up claims rather than independently verified commercial economics.

Read at source ↗

DTT summary based on FluoRok's report. The full article is on the publisher's site.

Additional reporting

Announced financing

$30 million (£22.8 million) Series A.

Funding caveat

Release also includes about $1.3 million (£1 million) Innovate UK grant; equity-only reconciliation not disclosed.

Lead investor

Orano Venture Fund / Supernova Invest.

Technology

Mechanical activation and base chemistry bypass hydrogen fluoride in fluorochemical manufacturing.

Next step

Demonstrator facilities and larger-scale customer validation, not completed industrial rollout.

Browse more DeepTech news →

Who's raising. Who's funding. What's next in DeepTech.